Patients | Treatment group | ||
---|---|---|---|
Ciprofloxacin | Placebo | ||
Number included | 7 | 11 | |
Sex M/F | 2/5 | 8/3 | |
Age (years) median (range) | 33 (18–52) | 45 (26–72) | |
HLA-B27 positive | 2 | 3 | |
Duration of disease (years, (SD)) | 1.9 (1.4) | 2.0 (1.5) | |
Cure | 6 | 5 | |
Partial clinical cure | 1 | 2 | |
Failure | 0 | 2 | |
Not evaluable | 0 | 2 |